• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病:流行病学与自然史

Non alcoholic fatty liver: epidemiology and natural history.

作者信息

Masarone Mario, Federico Alessandro, Abenavoli Ludovico, Loguercio Carmela, Persico Marcello

机构信息

Via Alessandro Manzoni 26b, 80123, Naples, Italy.

出版信息

Rev Recent Clin Trials. 2014;9(3):126-33. doi: 10.2174/1574887109666141216111143.

DOI:10.2174/1574887109666141216111143
PMID:25514916
Abstract

Non Alcoholic Fatty Liver Disease (NAFLD), defined as the presence of a significant amount of lipid accumulation in the liver (at least in 5% of hepatocytes), represents a challenging issue for the Hepatologists. NAFLD is not represented by a single entity, but rather by two different entities that have different natural history and evolution that range from simple fat accumulation in the liver (without any consequence), to necroinflammation, fibrosis, cirrhosis and hepatocellular carcinoma (HCC). The reason of these differences has to be found in the host characteristics and associated risk factors. Globally, its prevalence among liver diseases, and in the general population, is rising in the recent years along with its associated conditions: obesity, insulin resistance, metabolic syndrome and diabetes. This increment, together with the reported clinical conditions, may be accounted for changes in dietary habits and the increase of sedentary lifestyle. Its diffusion seems to be pandemic, given that it is beginning to affect the populations in the developing world due to the spread of Western lifestyle. This is particularly worrying in young adults and children in what seems to have become the main cause of liver disease. Even if the real rate of global incidence of NAFLD are not known, its worldwide prevalence in general population is estimated to be 20-30% in Western Countries and 5-18% in Asia and it is increasing over time. In this review we will report on the global and regional prevalence of NAFLD, the principal risk factors and the natural history of its different presentations.

摘要

非酒精性脂肪性肝病(NAFLD)被定义为肝脏中存在大量脂质蓄积(至少5%的肝细胞受累),这对肝病学家来说是一个具有挑战性的问题。NAFLD并非单一的疾病实体,而是由两种不同的实体组成,它们具有不同的自然史和演变过程,范围从肝脏单纯脂肪蓄积(无任何后果)到坏死性炎症、纤维化、肝硬化和肝细胞癌(HCC)。这些差异的原因必须从宿主特征和相关危险因素中寻找。在全球范围内,近年来其在肝脏疾病以及普通人群中的患病率连同其相关疾病(肥胖、胰岛素抵抗、代谢综合征和糖尿病)一起呈上升趋势。这种上升,连同所报告的临床情况,可能是由于饮食习惯的改变和久坐不动生活方式的增加所致。鉴于西方生活方式的传播开始影响发展中世界的人群,其传播似乎呈全球流行态势。这在年轻人和儿童中尤其令人担忧,因为它似乎已成为肝病的主要原因。即使NAFLD的全球实际发病率尚不清楚,但据估计其在西方国家普通人群中的全球患病率为20% - 30%,在亚洲为5% - 18%,且随时间推移呈上升趋势。在本综述中,我们将报告NAFLD的全球和区域患病率、主要危险因素及其不同表现形式的自然史。

相似文献

1
Non alcoholic fatty liver: epidemiology and natural history.非酒精性脂肪性肝病:流行病学与自然史
Rev Recent Clin Trials. 2014;9(3):126-33. doi: 10.2174/1574887109666141216111143.
2
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学与自然史
Semin Liver Dis. 2015 Aug;35(3):221-35. doi: 10.1055/s-0035-1562943. Epub 2015 Sep 17.
3
Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.非酒精性脂肪性肝病所致肝细胞癌的流行趋势。
Expert Rev Gastroenterol Hepatol. 2019 Feb;13(2):179-187. doi: 10.1080/17474124.2019.1549989. Epub 2018 Dec 29.
4
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
5
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.非酒精性脂肪性肝病、代谢风险因素与肝细胞癌:一个悬而未决的问题。
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
6
Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.热量均衡饮食变化与高心血管代谢风险个体的非酒精性脂肪肝
Nutrients. 2017 Sep 26;9(10):1065. doi: 10.3390/nu9101065.
7
The epidemiology of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的流行病学。
Liver Int. 2017 Jan;37 Suppl 1:81-84. doi: 10.1111/liv.13299.
8
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.系统评价:成人非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学和自然史。
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.
9
Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.非酒精性脂肪性肝病相关肝细胞癌:一个日益严重的问题。
Semin Liver Dis. 2015 Aug;35(3):304-17. doi: 10.1055/s-0035-1562949. Epub 2015 Sep 17.
10
Non-alcoholic fatty liver disease: A poorly known pandemic.非酒精性脂肪性肝病:一种鲜为人知的大流行疾病。
Med Clin (Barc). 2017 Dec 20;149(12):542-548. doi: 10.1016/j.medcli.2017.06.026. Epub 2017 Jul 24.

引用本文的文献

1
Two faces of the same coin non alcoholic fatty liver disease; with and without diabetes: Comparative clinico pathological analysis: A cross sectional observational study.同一硬币的两面:非酒精性脂肪性肝病;伴糖尿病和不伴糖尿病:比较临床病理分析:一项横断面观察性研究
J Family Med Prim Care. 2025 Jan;14(1):56-61. doi: 10.4103/jfmpc.jfmpc_1208_23. Epub 2025 Jan 13.
2
Serum folate levels and risk of metabolic dysfunction-associated steatotic liver disease: results from a cross-sectional study and Mendelian randomization analysis.血清叶酸水平与代谢功能障碍相关脂肪性肝病风险:一项横断面研究和孟德尔随机化分析的结果
Front Nutr. 2024 Sep 4;11:1437183. doi: 10.3389/fnut.2024.1437183. eCollection 2024.
3
Involvement of microbiota and short-chain fatty acids on non-alcoholic steatohepatitis when induced by feeding a hypercaloric diet rich in saturated fat and fructose.
当通过喂食富含饱和脂肪和果糖的高热量饮食诱导非酒精性脂肪性肝炎时,微生物群和短链脂肪酸的作用。
Gut Microbiome (Camb). 2022 Apr 8;3:e5. doi: 10.1017/gmb.2022.2. eCollection 2022.
4
The effects of meal patterns on liver steatosis, fibrosis, and biochemical factors in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial.饮食模式对非酒精性脂肪性肝病患者肝脏脂肪变性、纤维化及生化指标的影响:一项随机对照临床试验
J Diabetes Metab Disord. 2024 Jan 5;23(1):987-997. doi: 10.1007/s40200-023-01375-2. eCollection 2024 Jun.
5
Modern-Day Therapeutics and Ongoing Clinical Trials against Type 2 Diabetes Mellitus: A Narrative Review.现代治疗方法与2型糖尿病的正在进行的临床试验:一项叙述性综述
Curr Diabetes Rev. 2025;21(6):59-74. doi: 10.2174/0115733998294919240506044544.
6
Evaluating cardiovascular risk in metabolic steatosis with precision medicine non-invasive approaches: insights from a cohort study.采用精准医学非侵入性方法评估代谢性脂肪变性的心血管风险:来自队列研究的见解。
Intern Emerg Med. 2024 Nov;19(8):2293-2307. doi: 10.1007/s11739-024-03626-3. Epub 2024 May 16.
7
Effects of Egg Consumption on Subjects with SLD or Hypertension: A MICOL Study.鸡蛋摄入对 SLD 或高血压患者的影响:一项 MICOL 研究。
Nutrients. 2024 Jan 31;16(3):430. doi: 10.3390/nu16030430.
8
Diet quality indices and odds of metabolic dysfunction-associated fatty liver disease: a case-control study.饮食质量指数与代谢功能障碍相关脂肪性肝病的患病几率:一项病例对照研究。
Front Nutr. 2024 Jan 8;10:1251861. doi: 10.3389/fnut.2023.1251861. eCollection 2023.
9
Macrophages and the development and progression of non-alcoholic fatty liver disease.巨噬细胞与非酒精性脂肪性肝病的发生和进展。
Front Immunol. 2023 Jun 12;14:1195699. doi: 10.3389/fimmu.2023.1195699. eCollection 2023.
10
Association of serum folate with prevalence of non-alcoholic fatty liver disease among adults (NHANES 2011-2018).成人血清叶酸与非酒精性脂肪性肝病患病率的关联(2011 - 2018年美国国家健康与营养检查调查)
Front Nutr. 2023 Apr 11;10:1141156. doi: 10.3389/fnut.2023.1141156. eCollection 2023.